More From Our Sponsor:
Apexus

SPONSORED CONTENT

The 340B drug pricing program is a critical resource for covered entities and stakeholders, providing access to affordable medications for vulnerable patient populations. To ensure that you are well equipped to navigate the complexities of the program, the Apexus Advanced 340B Operations Certificate Program is excited to introduce our new advanced 340B education offerings! These programs aim to provide you with comprehensive and up-to-date information on the latest trends and hot topics in the 340B landscape.

Master Classes: A Sneak Peek into Advanced 340B Education

Stay ahead of the curve by signing up for our master classes presented by the Apexus Advanced 340B Operations Certificate Program, held quarterly at no charge. Each master class is designed to cover the most relevant and timely developments and challenges facing 340B stakeholders. Whether you are a covered entity or a non-covered entity stakeholder, these

SPONSORED CONTENT

The Health Resources and Services Administration (HRSA) conducts randomized audits to assess compliance with the 340B drug pricing program, a federal initiative aimed at providing discounted medications to eligible entities. With more than 13,100 parent entities participating in 340B, this increased participation comes with the responsibility of increased oversight and the likelihood of audits. It’s no longer a question of whether you’ll be audited; it’s a matter of when.

Covered entities with leading practice program auditing processes benefit from continuous insight into program performance, which supports ongoing improvement efforts and perpetual compliance, ultimately allowing these organizations to stretch their resources as far as possible. Apexus provides tools and resources that give guidance on how to optimize a 340B program, minimize noncompliance issues, and effectively prepare for a HRSA audit through the Apexus Advanced 340B Operations Certificate Program.

Managing Expectations: What to Expect During a HRSA Audit
Randomized HRSA